Engineered E. coli Boosts Immunotherapy via Nitric Oxide
In a groundbreaking advancement poised to reshape cancer immunotherapy, researchers have engineered a strain of bacteria capable of sustaining nitric...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In a groundbreaking advancement poised to reshape cancer immunotherapy, researchers have engineered a strain of bacteria capable of sustaining nitric...
A groundbreaking study recently published in Cell Reports reveals an unexpected role for the well-known immune checkpoint protein PD-L1 in...
In a groundbreaking advancement at the intersection of microbiology and cancer immunotherapy, researchers have engineered a strain of Escherichia coli...
Engineers at the University of Pennsylvania have unveiled a groundbreaking advancement in cancer immunotherapy with the development of a novel...
In a groundbreaking advancement against one of the most pervasive bacterial infections worldwide, researchers at the Technical University of Munich...
In a groundbreaking advancement for the treatment of leptomeningeal metastasis (LM) in breast cancer patients, researchers at The University of...
In a groundbreaking study poised to reshape our understanding of pancreatic cancer biology, researchers have unveiled how the epigenetic landscape...
In a groundbreaking study set to reshape our understanding of glioblastoma progression, researchers have identified glutamate decarboxylase 1 (GAD1) as...
Cancer therapy has long been hampered by the challenge of chemotherapy-induced thrombocytopenia (CIT), a condition characterized by dangerously low platelet...
In a groundbreaking new study published in Nature Communications, researchers unveil a novel immune checkpoint pathway with profound implications for...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine